Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
RAMSAY GENERALE DE SANTE : Availability of the 2026 URD - Evolution in the Governance - Annual General meeting on 4th December 2026
-
Aditya Birla Sun Life AMC International (IFSC) Limited introduces two retail funds of funds from GIFT City
-
Worldview Global Impact and HKUST Formalize Partnership to Deliver Columbia SIPA Executive Education in Hong Kong
-
Share Buy-back Programme – Transactions Week 42
-
Borders Tree Services Builds a Stronger Reputation Through Growing Five-Star Customer Recognition
-
Leatherneck Tree Service Gains Recognition Across Pennsylvania as More Customers Share Positive Experiences
-
Capitan Expands High-Grade Silver Mineralization to 600 Metres Down-Dip and Announces New CRD Discovery at Cruz De Plata
-
PetroTal Announces Board Change and Appointment of Emily Morris as Head of Investor Relations
-
Eco (Atlantic) Oil and Gas Ltd. Announces Completion of Direct Equity Subscription
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - October 19
-
Caledonia Mining Corporation Plc: Notification of Relevant Change To Significant Shareholder
-
PureTech Announces Presentation of Phase 1b Results for LYT-200 in Relapsed/Refractory (R/R) High-Risk Myelodysplastic Syndromes (HR-MDS) and Acute Myeloid Leukemia (AML) at ESMO 2026
-
eLstar Dynamics Launches the World’s First Commercial ELM Smart Glass Solution for Architectural Glazing, Harking in a New Era for Controlling Sunlight Without Compromising Design
-
Global Startup EXPO and Nippon Startup Awards 2026: METI Showcases Japan's Deep-tech Results
-
Egide - Half-year results at June 30, 2026: Net loss more than halved, amounting to €0.87m, Net financial debt reduced to €4.99m
-
Oculis lýkur slembiröðun í PREDICT-1 skráningarrannsókninni á Licaminlimab við TNFR1-miðluðum augnþurrki
-
Oculis Completes Randomization in PREDICT-1 Registrational Trial of Licaminlimab for TNFR1-Mediated Dry Eye Disease
-
tpay Selected as Vodafone Qatar’s Direct Operator Billing Aggregator
-
NBPE Announces Transaction in Own Shares
-
OSB GROUP PLC - Transaction in Own Shares
-
ALSTOM S.A: Alstom secures a first tranche order worth approximately €800 million in Vietnam
-
Nouscom Raises €120 Million ($135 Million) in Oversubscribed Series D Financing and will Present Long-Term Cancer Interception Clinical Data in Lynch Syndrome Carriers at ESMO
-
MKI Global Partners expands into emerging markets with focus on Latin America
-
Hemogenyx Pharmaceuticals PLC Announces Feasibility Study Agreement
-
Poxel Reports Revenue for the Third Quarter of 2026
-
Azelis: Transparency notifications from UBS Group AG
-
Allegiance Resources Appoints University of Nevada, Reno Department Chair and Extractive Metallurgy Professor Dr. Ehsan Vahidi to Advisory Board to Guide Tungsten Processing
-
OSE Immunotherapeutics Reports Positive Topline Results of Combi-TED Phase 2 Randomized Trial with Tedopi® (OSE2101) in metastatic Non-Small Cell Lung Cancer
-
Telix and Ekalia to Collaborate on Astatine-211 Production in the U.S.
-
Cabka’s emission reduction targets validated by the Science Based Targets initiative
-
Ekalia takes an important step in the deployment of Astatine-211 in the United States through a collaboration agreement with Telix
-
OSE Immunotherapeutics Reports Positive Topline Results of Combi-TED Phase 2 Randomized Trial with Tedopi® (OSE2101) in metastatic Non-Small Cell Lung Cancer
-
4th Liangzhu Forum Opens in Hangzhou to Facilitate Global Heritage Dialogue
-
5 Things to Know About PLUS Mainnet and Its Approach to Web3 Infrastructure
-
Cosmo Announces Positive Phase 2 Study of Rifamycin 1% Topically Acting Gel, Meeting the Primary Endpoint in Distal Ulcerative Colitis and Ulcerative Proctitis
-
Best Crypto to Invest In: Pepeto Eyes as Visa Backs USDC, XRP and Cardano Watch
-
BW LPG Limited – Update on BW LPG’s Product Services Q3 2026 Segment Performance
-
Genentech to Present Pivotal Data at ESMO 2026, Showcasing Advances Across Its Lung and Breast Cancer Late-Stage Portfolio
-
Mon courtier énergie group: Net Income Up 80% in the First Half of 2026, Driven by Growth and Improved Profitability
-
Trend Micro Announces Up to ¥10 Billion toward Cyber Resilience Initiative to Strengthen Security for Japanese Organizations in the AI Era
-
Red Cat Announces Proposed Voluntary Public Purchase Offer for Steyr Motors
-
JJP Biologics Doses the First Patients in Phase 1b Clinical Trial of Nebaprubart in Rheumatoid Arthritis (RA)
-
Start of Day Message
-
RUBIS ANNOUNCES A PROPOSAL TO CONVERT THE GROUP INTO A JOINT-STOCK COMPANY (SOCIÉTÉ ANONYME)
-
Zealand Pharma announces positive topline results from the multiple ascending dose part of Phase 1 trial with Kv1.3 ion channel blocker ZP9830
-
Roche to present pivotal data at ESMO 2026, showcasing advances across its lung and breast cancer late-stage portfolio
-
Aktsiaselts Infortar own share acquisition transactions
-
Ackermans & van Haaren increases its stake in Van Moer Logistics to 40%
-
IBA launches NEPTIS® Perform Duo, one synthesizer module from tracer development to routine production
-
SALMON SECURES $140 MILLION (PHP 8.8 BILLION) TO DOUBLE DOWN ON THE GROWTH OPPORTUNITY IN THE PHILIPPINES
